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The demonstration that Concanavalin A (Con A), 1 a polyclonal T-cell activa- 
tor, mimics antigen in generating cytotoxic T lymphocytes (CTL) from normal 
lymphocytes (1-4) may help in defining not only the molecular nature of the 
stimulating antigenic determinants but also in identifying receptors on pre- 
killer cells involved in the activation process (5). If Con A and antigenic activa- 
tion processes are mediated by similar pathways and by the same receptors, two 
predictions may be made: (a) It should be possible to use Con A and stimulating 
antigens interchangeably in the activation of secondary CTL and (b) antigenic 
stimulation should result in both specific  activation and,  to a  lesser extent, 
nonspecific polyclonal activation. 
This report tests the first prediction, i.e., whether lymphocytes primed to an 
allograft can be activated specifically into secondary cytotoxic T lymphocytes (2  ° 
CTL) by  Con  A.  The  secondary cytotoxic response  was  chosen to  test  this 
hypothesis because it characteristically appears early and is stronger than the 
primary response (6-8). The results reported here demonstrate that splenocytes 
primed to alloantigens can be activated in vitro into secondary CTL by both Con 
A. The cytotoxic activity is qualitatively indistinguishable from that obtained 
by antigenic stimulation. 
Materials and Methods 
Mice.  C57BL/6  (H-2 °)  and  BALB/c (H-2 d)  mice,  8-  to  12-wk  old,  were  obtained  from  the 
Mammalian Genetics and Animal Production Section,  Cancer Chemotherapy, National Service 
Center, National Cancer Institute. 
Tumors.  The following transplantable, ascitic tumors were maintained by weekly i.p. inoc- 
ulation of 1 ×  107 tumor cells into the syngeneic host: EL-4 (a chemically induced lymphoma) in 
C57BL/6 mice and G-35 (a Gross virus-induced lymphoma) in BALB/c mice. D-6 (H-2 ~) lymphoma 
was established in culture by Dr. E. Hays, U.C.L.A., from a spontaneous leukemia developed in 
C3H mice. 
Immunizations.  10-20 million tumor cells were injected i.p.  into the appropriate allogeneic 
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host: EL-4 (H-2 b) into BALB/c (H-2 d) mice, and G-35 (H-2 ~) into C57BL/6 (H-2 b) mice. The immune 
mice were sacrificed 40-60 days after inoculation. 
In Vitro Sensitization.  Cultures were set in Falcon 50-ml flasks (cat. no. 3023), each contain- 
ing a total of 25 × 10  ~  responder cells and 5 × l0  s stimulator cells (treated with 30 t~g mitomycin C/ 
107 cells) in 10 mt RPMI 1640 supplemented with 10% heat-inactivated fetal calf  serum, 5 × 10  5 M 
2-mercapthoethanol, 15  mM  Hepes buffer, 2  mM glutamine,  and  1%  antimycotic-antibacterial 
mixture. The flasks were incubated in a horizontal position in a humidified atmosphere of 5% CO2 
and 95% air at 37°C. Cells were harvested at 42-72  h, washed twice in phosphate-buffered  saline, 
counted for viability, and brought to the desired cell concentration. 
Con A  Activation.  This  was set as  above with the exception that Con A  (Type IV,  Sigma 
Chemical Co., St. Louis, Mo.) was added at the desired concentration. The preparation of  blasts for 
use as target cell was done as described previously (9). 
Assays for Cell-Mediated Cytotoxicity.  The 5JCr release assay was used as described previously 
using 10 ~ ~Cr-target cells (9).  Cytotoxic activity was occasionally expressed in lytic units per 
spleen as  described by  Cerottini et al.,  with the exception that  one lytic unit was defined to 
represent the number of effector cells that kill 30% of the target (7).  Lectin-dependent cellular 
cytotoxicity (LDCC) was performed as described previously (10). 
Fractionation on Cell Monolayers.  Adsorption of immune cells was carried out by the tech- 
nique we have previously described (11). 
[~H]thymidine Incorporation.  Proliferation was assessed by  [~H]thymidine incorporation. A 
sample (0.3 ml) was taken from the culture flask, washed, resuspended in 0.6 ml fresh media, and 
dispensed in 0.2-ml aliquots in microtiter plates. To each well 1 t~Ci [3H]thymidine was added and 
the plates incubated for 6 h. The cells were harvested on a MASH multiharvester and counted for 
radioactivity. The results are expressed as  mean count  -+  SD of triplicate samples with back- 
ground substracted. The background was usually less than 400 cpm. 
Heterologous Anti-T Serum.  Specific heterologous anti-mouse thymocyte serum was prepared 
in rabbits as described (12). 
Results 
Con A-Induced Activation  of In  Vivo Primed Splenocytes  to a  Tumor Allo- 
graft  into  Secondary  Cytotoxic  Lymphocytes.  Primed  splenocytes  against  a 
tumor allograft were cultured for 3-4 days with either the priming alloantigen 
or with Con A and tested for cell-mediated cytotoxicity by the 51Cr release assay 
(Table  I).  The  stimulation  in  one-way  mixed  lymphocyte  tumor  reaction  re- 
sulted in  a  very strong and specific cytotoxic activity  against the stimulating 
target.  In the absence of stimulating antigen,  Con A also activated the primed 
splenocytes  into  cytotoxic  lymphocytes  with  specificity  directed  against  the 
priming alloantigen.  The  Con A-induced activation  of CTL was shown in two 
different  systems,  namely,  primed BALB/c  anti-EL-4  and  C57BL/6  anti-G-35. 
Cytotoxicity was not restricted to tumor target cells since 5~Cr C57BL/6 blasts 
served  as  good  as  5~Cr EL-4  tumor  (Exp.  4).  Titrations  of effector  cells  as  a 
function of cytotoxic activity resulted in a  linear relationship,  and the slope of 
the curves was similar for both alloantigen and Con A activation.  Phytohemag- 
glutinin (PHA) was also able to activate 2  ° CTL in a manner similar to Con A. 
Lipopolysaccharide,  a B-cell mitogen,  however, was not effective  (Exp.  5). 
Normal  splenocytes  cultured with  Con A  were  found to be not cytotoxic to 
syngeneic or allogeneic target cells.  Failure to detect Con A-induced polyclonal 
activation  was due to the  assay  conditions used  in this  study,  namely,  short 
cytotoxic assays (2-3 h) and low effector to target cell ratios (<20:1).  Polyclonal 
activation was revealed when optimum conditions for demonstrating polyclonal 
activation were achieved,  i.e.,  longer assay periods (18-36 h) and high effector 
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TABLE  I 
Con A-Induced Activation of In Vivo Primed Alloimmune Splenocytes into Secondary 
Cytotoxic Lymphocytes* 
Exp.  Responder splenocytes  Stimulator  Con A  Day 
no.  tested 
Percent specific s'Cr release  (E:T 20:1) 
EL-4 (H-26)  G-35 (H-2 d) 
tLglml 
1  BALB/c anti-EL-4 (50d)  EL-4  -  3  31.5  ±  3.9  1.6  ±  1.5 
BALB/c anti-EL-4 (50d)  -  0.25  3.2  ±  0,4  2.0  ±  1.1 
BALB/c anti-EL-4 (50d)  -  0.5  28.6  ±  0.6  4.3  ±  0.5 
BALB/c anti-EL-4 (50d)  -  1.0  30.0  ±  1.0  1.8  ±  0.8 
Normal BALB/c  EL-4  -  12.8  ±  1.2  0.6  ±  0.3 
Normal BALB/c  -  0.25  0.17 ± 0.5  2.1 ± 0.8 
Normal BALB/c  -  0.5  3.9  ±  0.7  2.6  ±  0.2 
Normal BALB/c  -  1.0  7.4  ±  1,2  3.6  ±  0.7 
Normal BALB/c~  -  1.0  32.4  ±  0,7 
EL-4 (H-2  ~)  D-6 (H-2  ~) 
2  BALB/c anti-EL-4 (40d)  EL-4  -  4  63.2  ±  2.1  8.8  ±  0.6 
BALB/c anti-EL-4 (40d)  -  1.0  55.3  -+  3.5  6.0  -+ 0.1 
BALB/c anti-EL-4 (40d)  -  2.0  51.6  ±  2.3  9.2  ±  0.4 
BALB/c anti-EL-4 (40d)  -  4.0  49.3  ±  2.3  9.3  ±  0.2 
BALB/c anti-EL-4 (40d)  -  -  0.9 ± 0.4  1.6 ±  1.0 
Normal BALB/c  EL-4  -  49.1  ±  0.7  4.7  ±  0.2 
Normal BALB/c  -  1.0  3.2  ±  0.6  1.6  ±  0.5 
Normal BALB/c  -  2.0  4.5  ±  0.3  2.5  ±  0.7 
Normal BALB/c  -  4,0  8.2  ±  0.8  2.5  ±  0.4 
EL-4 (H-2 ~)  G-35 (H-2 ~) 
3  BALB/c anti-EL-4 (60d)  EL-4  -  3  22.3  ±  0.4  0.6  ±  0.4 
BALB/c anti-EL-4 (60d)  -  1.0  38.7  ±  0.8  0.1  ±  1.4 
BALB/c anti-EL-4 (60d)  -  -  0.3  ±  0.9  0.3  ±  0.5 
EL-4 (H-2 b)  G-35 (tt-2 d) 
C57BL/6 anti-G-35 (60d)  G-35  -  0.5  ±  0,1  52.9  ±  1.4 
C57BL/6 anti-G-35 (60d)  -  1.0  0.6  ±  0.2  20.7  ±  1,1 
C57BL/6 anti-G-35 (50d)  -  1,6 ±  0.4  6,6 +_ 0.6 
BALB/c anti-EL-4 (60d)  EL-4  -  4  41.6  ±  2.9 (57)§  1.9 ±  0.5 
BALB/c anti-EL-4 (60d)  -  1.0  33.8  ±  0.8 (40.2)  2.6 ±  0.9 
BALB/c anti-EL-4 (60d)  -  -  2.0  ±  0.3  1.8  ±  0.4 
C57BL/6 anti-G-35 (60d)  G-35  0.4  ±  0.2  51.3  -+  1.1  (400) 
C57BL/6 anti-G-35 (60d)  -  1.0  0.9  ±  0.7  36.3  ±  1.4 (35.3) 
C57BL/5 anti-G-35 (60d)  -  -  0.5  ±  0.9  6.6  ±  0.6 
Normal C57BL/6  G-35  -  0.9  ±  0.7  11.5  ±  0.6 
Normal C57BL/6  -  1.5  0.1  ±  O.1  3.6  ±  0.7 
EL-4  C57BL/6 blasts 
4  BALB/c anti-EL-4 (60d)  -  1.0  3  53.2  ±  0.9  52.6  ±  1.9 
BALB/c anti-EL-4 (60d)  EL-4  -  79.0  ±  0.9  68.8  ±  2.1 
BALB/c anti-EL-4 (60d)  C57BL/6  -  79.1  ±  1.1  72.2  ±  2.8 
BALB/c anti-EL-4 (60d)  -  -  1.3  ±  0.3  1.3  ±  1.2 
EL-4 (H-2 b) 
5  BALB/c anti-EL-4 (50d)  EL-4  -  3  69.9  ±  2.1 
BALB/c anti-EL-4 (50d)  -  1.0  50.9 ± 0.4 
BALB/c anti-EL-4 (50d)  -  PHA~I 0.1 pl  74.4 ± 2.5 
BALB/c anti-EL-4 (50d)  0.01  /zl  1.9  ±  0,3 
BALB/c anti-EL-4 (50d)  0.005/~l  2.7  ±  0.2 
BALBIc anti-EL-4 (50d)  LPS  10  ~glml  3.9  ±  0.4 
* Mice were primed in vivo to a tumor allograft and 40-60 days (d) later the spleens were removed  and cultured in the presence of 
stimulating antigen or Con A. 
In this experiment the cytotexic assay was extended to 16 h in order to demonstrate polyclonal  activation. 
§ The numbers in parentheses represent the number of  lytic  units recovered in the culture. 
II  PHA  was obtained from Wellcome Burroughs, England, and each vial was diluted to  5 ml. From this stock solution various amounts were 
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FIo.  1.  Several  replicate cultures of primed BALB/c  anti-EL-4 were incubated alone, with 
EL-4m, and with Con A and tested daily for beth cytotoxic activity to ~'Cr EL-4 cells and 
incorporation of [3H]thymidine (see Materials and Methods). The effector-target ratio used 
here was 20:1. 
Kinetics  of the Proliferative and Cytotoxic Responses After Antigenic Stimu- 
lation and Con A Activation.  With Con A concentrations of 0.5 and 1.0 ~g/ml, 
both radioactive incorporation  and CTL activity reached a  maximum at day 3 
and then declined at day 4 (Fig. 1). With <0.5 gg/ml Con A, weak CTL activity 
and  relatively  weak  incorporation  of radioactivity  was  obtained.  Antigenic 
stimulation resulted in maximum CTL and radioactive incorporation at day 4. 
These experiments demonstrated that Con A activation of CTL follows the same 
early kinetics observed aider secondary antigenic stimulation, and the prolifera- 
tive response appears to parallel the cytotoxic response. 
Properties of Cytotoxic Effector Cells Activated by Con A.  The specific Con A 
inhibitor,  a-methyl-D-mannose  pyranoside  (a-mm)  failed  to  inhibit  (cell-me- 
diated cytotoxicity (CMC) of effector cells generated by Con A  demonstrating 
that CMC is not mediated by contaminant Con A present in the cultures (Table 
II, Exp.  1). 
Other properties of Con A-induced CTL are summarized in Table III. Treat- 
ment with specific anti-T serum and complement abrogated cytotoxicity demon- 
strating that the effector cells are thymus dependent. The cytotoxic activity was BENJAMIN BONAVIDA 
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Exp.  Effector lymphocytes  Inhibitor a-mm  CMC*  LDCC$ 
no. 
M 
BALB/c anti-EL-4§  -  38.8  ±  0.2  20.8  _+  0.3 
BALB/c anti-EL-4§  2.5  x  10 -~  38.8  -+ 0.9  (0)  3.8  -+ 0.5  (82)11 
BALB/c anti-EL-4§  5  x  10 -~  39.8  ±  1.6 (0)  12.4  -+ 0.6 (40) 
BALB/c anti-EL-4§  10 -2  39.2  +- 0.3  (0)  20.6  -+ 0.1  (0) 
BALB/c anti-EL-4§  33.8  -+ 0.8  22.4  -+  1.3 
BALB/c anti-EL-4¶  41.6  -+  2.9  12.5  +-  1.5 
C57BL/6 anti-G-35§  36.3  -+  1.4  10.0  -+  1.4 
C57BL/6 anti-G-35¶  61,3  _+  1.1  41.3  ±  3.0 
* CMC was assessed against 5~Cr EL-4 or s~Cr G-35 at an effector-target ratio of 20:1. 
LDCC was assessed against 5~Cr D6 (H-2 ~) target cells in the presence of 1.0 ~g Con A  (Exp. 1) 
and against syngeneic 51Cr EL-4 or 5~Cr G-35 target cells in the presence of 10 ~l PHA (Exp. 2). 
§ Activated by Con A  (1.0/~g/ml). 
II The numbers in parentheses represent the percent inhibition obtained in the presence of  the Con 
A  inhibitor a-ram. 
¶ Activated by antigen. 
TABLE III 
Properties of Cytotoxic Effeetor Cells Activated by Concanavalin A and by Alloantigens 
CMC to s~Cr EL-4  Percent 
Effector cells  Activation  Treatment  5:1  inhibition 
BALB/c anti-EL-4 (60d)  Con A (1 ~g/ml)  None  34.6 ± 1.0 
BALB/c anti-EL-4 (60d)  Con A (1 pg/ml)  Absorbed  on BALB/c monolayer*  38.0 ± 1.1 
BALB/c anti-EL.4 (60d)  Con A (I ~g/ral)  Absorbed on C57BL16 monolayer  0.7 ± 0,6  98 
BALB/c anti-EL-4 (60d)  Con A (1 /Lg/ml)  Anti-T serum + C'  3.6 ± 1,9  90 
BALB/c anti.EL-4 (60d)  Con A (1 ~g/ml)  Adherence to  plastic*  36.2 ± 0.3 
BALB/c anti-EL-4 (60d)  EL-4m  None  41.3 ± 0.7 
BALB/c anti-EL-4 (60d)  EL-4m  Absorbed on BALB/c monolayer  39.5 ± 0.3 
BALB/c anti-EL-4 (CA}d)  EL-4m  Absorbed on C57BL/6 monolayer  6.4 ± 0,7  85 
BALB/c anti-EL-4 (60d)  EL-4=  Anti-T serum + C'  4.8 ± 1.0  88 
BALB/c anti-EL-4 (60d)  EL-4m  Adherence to  plastic  43.3 ± 0.5 
d, days. 
* Experiments  with monolayer  absorptions  and adherence to plastic Petri dishes  were  done by testing the nonadherent fractions  for 
cytotoxic activity without readjustment of effector-target cell ratios. 
recovered in the nonadherent cell fraction, demonstrating that cells adherent to 
plastic are not the effector lymphocytes. Absorption of effector cells on monolay- 
ers prepared with the priming alloantigen specifically removed the cytotoxic 
effector cells, demonstrating antigenic specificity of the effector cells. 
Complementarity  of  Con  A  and  Antigen  in  Activation  of  2 °  CTL.  If 
activation  of 2  °  CTL  by  Con  A  and  alloantigen  is  mediated by  the  same 
mechanisms, it would be expected that mixtures of suboptimal concentration of 
Con A and antigen should be additive and stimulatory. Indeed, the addition of 
Con A to the cultures resulted in augmentation of CTL activity as measured by 
~tCr release and by total lytic activity recovered. This augmentation of cytolytic 
activity was also noticed with submitogenic concentrations of Con A (0.1-0.25 
~g/ml) and with nonstimulatory responder:target ratio (10,000:1). The augmen- 
tation of CTL activity was synergistic in all cases (Fig. 2). 298  CON A  ACTIVATION OF SECONDARY  CYTOTOXIC  LYMPHOCYTES 
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FIG.  2.  Primed BALB/c spleen cells to EL-4 were cultured in vitro with Con A, EL-4, or a 
mixture of Con .a, and EL-4.3 days later, the cells were tested for cytotoxic activity against 
:"Cr EL-4 cells. Three responder to stimulating ratios (R/S) were used to correspond to R/S 
100:1, R/S 1,000:1,  and R/S 10,000:1,  using constant number of responder splenocytes. Three 
effector:target cell ratios were used (20:1,  5:1, and 1.25:1), and an estimate of the number of 
lytic units for each culture was calculated and represented in parentheses. The results in 
the figure represent cytotoxicity at E:T of 5:1. 
Discussion 
Evidence is  presented which demonstrates that  primed splenocytes to  an 
allograft can be activated by Con A into secondary CTL with specificity for the 
priming alloantigens. The cytotoxic activity induced by Con A is independent of 
the presence of Con A in the cytotoxic assay, thus clearly not LDCC. The data is 
consistent in that identical populations of primed lymphocytes respond to either 
Con A or antigen and suggest that Con A binds to the antigen-binding receptors 
or to functionally similar receptors present on the membrane. This idea is best 
illustrated from several independent lines of evidence indicating the absence of 
obvious qualitative differences  in the CTL responses generated by Con A and by 
antigen, namely, Con A-induced activation resembles antigenic stimulation in 
the kinetics of appearance of CTL,  strength of CTL activity, and specificity of 
killing. Furthermore, mixture of  suboptimal concentrations  of Con A and stimu- 
lating antigen resulted in augmentation of CTL activity. 
The generation of CTL has been shown to be mediated by cooperation of at 
least  two  T-cell  subclasses  (5,  13). Our  present  studies  cannot  distinguish 
whether Con A  activation of 2  ° CTL directly triggers the prekiller cells (SD 
reactive cells),  the proliferating helper cell, or both cells.  The availability of 
specific  antisera  directed against  subclasses of T  cells should be  helpful in 
answering this question (14). 
The Con A activation of 2  ° CTL is reminiscent of the recently reported studies 
by Alter et al.  (15) who demonstrated that lymphocyte-defined (LD) antigens 
stimulate 2  ° CTL with specificity to the primary stimulating cellular antigens. 
These results and the work presented here suggest that Con A and LD antigens, 
or functionally similar antigens, may trigger prekiller cells by similar mecha- 
nisms via a single pathway. Accordingly, it may be expected that the triggering 
events induced by these  two  activating  agents  would be  indistinguishable. 
Several shared properties have been demonstrated here and in other studies: (a) 
Con A and LD antigens are mitogenic as demonstrated by [3H]thymidine incor- 
poration; (b) Con A and LD antigens both activate specific 2  ° CTL from antigeni- BENJAMIN BONAVIDA  299 
cally primed cells under similar assay conditions  (i.e.,  short-term assays with 
low E:T ratios). The cytotoxic activity generated is qualitatively indistinguisha- 
ble  and  in  many  cases  quantitatively  alike.  (c)  Since  Con  A  activation  is 
thought  to be nonspecific,  LD activation ought to be also nonspecific,  i.e.,  no 
requirement  for antigenic  identity of the priming  LD with the secondary LD 
stimulus.  Indeed,  studies  of Alter  et  al.  (15)  and  ours  (unpublished)  have 
demonstrated that activation of 2  ° CTL by LD antigen does not require homol- 
ogy with the primary LD. Targets with different LD determinants were able to 
trigger 2  ° CTL with specifcity to the primary antigens. The role of SD antigens 
in 2  ° CTL activation,  however, cannot be ruled out completely since SD anti- 
genic contaminants  may still be present with the primed responder cells.  (d) 
Con A  and  LD antigens  are  expected to be complementary in the  activation 
process.  Evidence  is presented  here  showing that  mixing  of suboptimal  non- 
mitogenic concentrations of Con A and antigen with primed responding lympho- 
cyte in  cultures  resulted  in  augmentation  of 2  ° CTL activity.  The  amplifica- 
tion was synergistic in several responder:target  ratios tested.  Synergism was 
also obtained with optimal mitogenic concentration of Con A. The synergenistic 
activity obtained may be the result of specific triggering of primed lymphocytes 
and/or expansion of responding cells by mitogenic factors. The augmentation of 
2  ° CTL activity by mitogenic Con A concentrations as shown here is in contrast 
to Con A-induced suppression of 1  ° CTL generation in one-way mixed leukocyte 
response  (16).  It  may  be that  primed  lymphocytes  are  refractory  to  Con  A- 
induced suppression. Further studies are being investigated to test this possibil- 
ity, and (e) Con A has been shown to be a polyclonal T-celt activator ofunprimed 
lymphocytes (1-4), whereas LD antigens have not been examined for polyclonal- 
ity.  In the  1  ° response,  LD  antigens  have  been  shown to  cooperate with  SD 
antigens  to generate strong and specific CTL,  and in the 2  ° CTL response LD 
antigens  bypass  the  SD  antigenic  requirement.  The  functional  role  of  LD 
antigens  in the  1  ° response vs. the 2  ° response may still be the same,  and the 
differences may be reconciled by assuming that LD antigens have low affinity 
for uncommitted prekiller cells and high affinity for primed cells. The activation 
of 1  ° CTL by LD antigens is helped by the SD antigens then serving as focusing 
device. By this mechanism,  specificity of CTL, rather than polyclonality, is also 
achieved by virtue of SD antigens binding to specific antigen-binding receptors 
present on corresponding clones of lymphocytes. 
In drawing a  comparison between Con A  and LD antigen function,  another 
question that remains to be investigated is whether LD antigens also play a role 
in the cytotoxic step of CMC. Con A has been shown to mediate nonspecific CMC 
by specifically immunized effector cells  (10,  17). The mechanism  of the LDCC 
reaction may be explained on the basis of contact between effector and target 
cells brought about by lectin agglutination. After the contact, Con A triggers the 
effector cell to induce cytotoxicity. It will be of interest of determine whether LD 
antigens  can  effectively mediate  nonspecific  cytotoxicity  by  similar  mecha- 
nisms. 
Our results indicate that there are functional similarities between Con A and 
LD antigens or functionally similar antigens in ability to stimulate CTL, and we 
propose  that  they  may,  in  fact,  be  stimulating  prekiller  cells  by the  same 
mechanism. 300  CON A ACTIVATION OF SECONDARY CYTOTOXIC LYMPHOCYTES 
Summary 
A secondary specific cytotoxic response is obtained when lymphocytes primed 
in vivo to a  tumor allograft are exposed to Con A  in culture.  The secondary 
cytotoxic cells  generated are  specific to target  cells bearing  antigens  of the 
primary sensitizing cells and are qualitatively indistinguishable from the re- 
sponse obtained upon secondary antigenic stimulation. The cell-mediated cyto- 
toxicity is independent of concanavalin A (Con A) and is not affected by the Con 
A-specific  inhibitor,  a-methyl-D-mannose pyranoside.  Furthermore,  cultures 
containing a  mixture of submitogenic concentrations of Con A and stimulating 
antigens showed synergy and augmentation of cytotoxic activity. It is suggested 
that activation of prekiller cells by Con A  into CTL may be mediated via the 
same  or  similar  receptors  normally  triggered  by  the  stimulating  antigens. 
Functional similarities between Con A and the lymphocyte-defined antigens of 
the major histocompatibility complex region are discussed. 
The author is grateful to Dr. Janet Roman and Elizabeth Grimm for their critical reading of the 
manuscript. The capable technical assistance of Barbara Ikejiri and secretarial assistance of 
Elizabeth Janes is acknowledged. 
Note Added in Proof.  Independent studies in agreement with our findings 
have  been  recently  reported  (Heininger,  D.,  M.  Touton,  A.  Chakrabarty, 
and W.  J.  Clark. J. Immunol.  In press. 
Received for publication 20 September 1976. 
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